Please upgrade your browser.
Argos Therapeutics Inc., a biopharmaceutical company focused on the development and commercialization of fully personalized immunotherapies for the treatment of cancer and infectious diseases using its Arcelis™ technology platform, announced that the first patients have been enrolled in the ADAPT Phase 3 clinical study for AGS-003, its most advanced product candidate.
A deadline for eliminating disparities by 2010 has come and gone.
India is taking another swipe at Big Pharma.
Investigators publish new report on Intercellular Signaling Peptides and Proteins. According to news reporting originating from Pittsburgh, Pennsylvania, by NewsRx correspondents, research stated, "Cancer is the leading cause of death in the United States in those dying under the age of 85.
Acrylamide (formed when potatoes are baked or fried) is correlated with a 60% higher rate of kidney cancer
Kidney Cancer Association, Urology Care Foundation, and Conquer Cancer Foundation welcome grant requests supported by donations from ShoeDazzle and celebrity Denise Richards.
Erik Brincks, PhD, University of Minnnesota, under the mentorship of Thomas S. Griffith, PhD. "The Influence of Obesity on the Immunotherapy of Renal Cell Carcinoma"
Thousands of individuals have had kidneys removed unnecessarily because doctors misdiagnosed their disease.
Apoptosis is the process of programmed cell death and is required for the correct development and tissue maintenance of an organism.
Developed by researchers in the Department of Biomedical Engineering (BME) at Stony Brook University, the contrast agent adheres to a molecular marker of medulloblastoma, a form of brain cancer, and can be seen by the optical microscope system, also developed by the research team.
|Powered by NeonCRM|